Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An open-label, two-treatment, two-sequence, two-period, balanced, randomized, single dose, cross over, comparative bioavailability study of ZYO1 tablet [20mg tablet and 5mg tablet - old (first) formulation] of M/S Cadila Healthcare Ltd., Ahmedabad, India with ZYO1 tablet [20 mg tablet and 5 mg tablet - new (second) formulation] of M/S Cadila Healthcare Ltd., Ahmedabad, India in healthy, adult, male, human subjects under fasting conditions.

X
Trial Profile

An open-label, two-treatment, two-sequence, two-period, balanced, randomized, single dose, cross over, comparative bioavailability study of ZYO1 tablet [20mg tablet and 5mg tablet - old (first) formulation] of M/S Cadila Healthcare Ltd., Ahmedabad, India with ZYO1 tablet [20 mg tablet and 5 mg tablet - new (second) formulation] of M/S Cadila Healthcare Ltd., Ahmedabad, India in healthy, adult, male, human subjects under fasting conditions.

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 30 Aug 2016

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs ZY 01 (Primary)
  • Indications Obesity
  • Focus Pharmacokinetics
  • Sponsors Cadila Healthcare
  • Most Recent Events

    • 23 Sep 2011 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top